4//SEC Filing
Townsend Richard Nolan 4
Accession 0001415889-25-009450
CIK 0001907108other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 7:58 PM ET
Size
5.0 KB
Accession
0001415889-25-009450
Insider Transaction Report
Form 4
Townsend Richard Nolan
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2025-03-14$2.61/sh+2,128$5,554→ 222,247 total
Footnotes (1)
- [F1]The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Lexeo Therapeutics, Inc. 2023 Employee Stock Purchase Plan. This transaction is exempt under both Rule 16b-3(c) and Rule 16b-3(d).
Documents
Issuer
Lexeo Therapeutics, Inc.
CIK 0001907108
Entity typeother
Related Parties
1- filerCIK 0001995218
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 7:58 PM ET
- Size
- 5.0 KB